Neuberger Berman Group LLC Buys 3,944 Shares of Plexus Corp. $PLXS

Neuberger Berman Group LLC boosted its stake in Plexus Corp. (NASDAQ:PLXS) by 193.3% in the second quarter, HoldingsChannel reports. The institutional investor owned 5,984 shares of the technology company’s stock after buying an additional 3,944 shares during the quarter. Neuberger Berman Group LLC’s holdings in Plexus were worth $810,000 as of its most recent SEC filing.

A number of other hedge funds have also recently bought and sold shares of PLXS. Huntington National Bank raised its holdings in shares of Plexus by 41.5% in the second quarter. Huntington National Bank now owns 324 shares of the technology company’s stock valued at $44,000 after purchasing an additional 95 shares during the last quarter. Banque Transatlantique SA bought a new stake in Plexus in the 1st quarter worth about $71,000. CWM LLC increased its stake in Plexus by 65.7% in the 2nd quarter. CWM LLC now owns 537 shares of the technology company’s stock valued at $73,000 after buying an additional 213 shares during the last quarter. EverSource Wealth Advisors LLC lifted its position in shares of Plexus by 583.3% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 574 shares of the technology company’s stock worth $78,000 after buying an additional 490 shares in the last quarter. Finally, TD Private Client Wealth LLC boosted its stake in shares of Plexus by 31.5% in the 2nd quarter. TD Private Client Wealth LLC now owns 676 shares of the technology company’s stock worth $91,000 after buying an additional 162 shares during the last quarter. 94.45% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Plexus

In other news, CEO Todd P. Kelsey sold 2,000 shares of the business’s stock in a transaction on Tuesday, November 4th. The shares were sold at an average price of $143.50, for a total transaction of $287,000.00. Following the completion of the transaction, the chief executive officer directly owned 60,714 shares in the company, valued at $8,712,459. The trade was a 3.19% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CFO Patrick John Jermain sold 2,000 shares of the company’s stock in a transaction dated Tuesday, November 11th. The stock was sold at an average price of $143.53, for a total value of $287,060.00. Following the completion of the transaction, the chief financial officer owned 16,961 shares in the company, valued at $2,434,412.33. This represents a 10.55% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders sold 13,172 shares of company stock worth $1,883,740. 1.76% of the stock is owned by corporate insiders.

Plexus Stock Performance

NASDAQ PLXS opened at $159.91 on Monday. The firm has a market cap of $4.28 billion, a P/E ratio of 25.54 and a beta of 0.81. The company has a quick ratio of 0.77, a current ratio of 1.58 and a debt-to-equity ratio of 0.06. The company’s 50 day moving average is $145.18 and its 200-day moving average is $138.56. Plexus Corp. has a 12-month low of $103.43 and a 12-month high of $172.89.

Plexus (NASDAQ:PLXS) last released its quarterly earnings data on Wednesday, October 22nd. The technology company reported $2.14 earnings per share for the quarter, beating analysts’ consensus estimates of $1.84 by $0.30. The business had revenue of $1.06 billion during the quarter, compared to analyst estimates of $1.05 billion. Plexus had a net margin of 4.29% and a return on equity of 12.77%. Plexus’s revenue was up .7% compared to the same quarter last year. During the same period in the previous year, the business earned $1.85 EPS. Plexus has set its Q1 2026 guidance at 1.660-1.810 EPS. Sell-side analysts predict that Plexus Corp. will post 5.9 earnings per share for the current year.

Analysts Set New Price Targets

PLXS has been the subject of a number of research analyst reports. Stifel Nicolaus set a $150.00 price target on Plexus in a research report on Friday, October 24th. Wall Street Zen downgraded Plexus from a “buy” rating to a “hold” rating in a research note on Saturday, November 22nd. Benchmark reiterated a “buy” rating and set a $165.00 target price on shares of Plexus in a research note on Friday, October 24th. Weiss Ratings restated a “hold (c+)” rating on shares of Plexus in a research report on Wednesday, October 8th. Finally, Williams Trading set a $165.00 price objective on shares of Plexus in a report on Monday, September 22nd. Two equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $159.00.

Plexus Profile

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.